MainTotal number of complaint letters regarding promotion materials reviewed in the monthOPDP is tracking the number of complaint letters regarding prescription drug promotion that it receives and reviews each month. OPDP’s objective is to review and acknowledge complaint letters within 30 days of their receipt and to further investigate complaints that appear to have merit. Complaint letters aid in the discovery of illegal promotional activities; the prompt review and acknowledgement of complaints will help encourage the submission of further valuable information by complainants. This in turn can serve as the first step in the action needed to identify and stop future misleading promotion. <br>These measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. </b> Number01002010FY 2010 Total: 1412011FY 2011 Total: 1172012FY 2012 YTD: 29http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER DashboardSubTotal number of complaint letters regarding promotion materials reviewed in the monthPercentage of complaint letters reviewed within 30 daysPercent010001002010010020111002012SubTotal number of complaint letters regarding promotion materials reviewed in the monthPercentage of complaint letters reviewed in the month appearing to have meritPercent010001002010010020111002012਍††਍਍਍਍਍਍਍